US Food and Drug Administration (US FDA) has successfully completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Sciences Limited (Solara) at Visakhapatnam, Andhra Pradesh.
SPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for this product for the treatment of seizures in newborns in February 2022, according to Sun Pharma statement shared with stock exchanges.
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Mumbai (Maharashtra) [India], Oct 7 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter to Glenmark Pharmaceuticals for breach of norms at its facility at Baddi in Himachal Pradesh.
Mumbai (Maharashtra) [India], Sep 19 (ANI): The US Food and Drug Administration (US FDA) has issued a warning letter to pharma major Lupin Ltd for its facility at Mandideep in Madhya Pradesh.